Arkadios Wealth Advisors Has $609,000 Stake in Core Laboratories Inc. $CLB

Arkadios Wealth Advisors reduced its holdings in Core Laboratories Inc. (NYSE:CLB) by 41.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,297 shares of the oil and gas company’s stock after selling 35,599 shares during the period. Arkadios Wealth Advisors owned 0.11% of Core Laboratories worth $609,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLB. Tower Research Capital LLC TRC grew its holdings in shares of Core Laboratories by 400.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after acquiring an additional 5,869 shares in the last quarter. Assetmark Inc. raised its holdings in Core Laboratories by 160.8% during the second quarter. Assetmark Inc. now owns 7,530 shares of the oil and gas company’s stock worth $87,000 after acquiring an additional 4,643 shares in the last quarter. Ingalls & Snyder LLC acquired a new position in Core Laboratories during the second quarter valued at approximately $115,000. Vanguard Personalized Indexing Management LLC acquired a new position in Core Laboratories during the second quarter valued at approximately $146,000. Finally, Praxis Investment Management Inc. bought a new position in Core Laboratories in the second quarter valued at approximately $155,000. 97.81% of the stock is owned by institutional investors.

Core Laboratories Stock Down 0.7%

CLB stock opened at $19.32 on Tuesday. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $20.36. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.37 and a quick ratio of 1.76. The stock has a market capitalization of $899.54 million, a price-to-earnings ratio of 28.84, a PEG ratio of 16.98 and a beta of 1.03. The business’s fifty day moving average price is $16.96 and its two-hundred day moving average price is $14.05.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $12.50.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.